F. James Primus
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 39
- Radiopharmaceutical Chemistry and Applications 35
- Immunology 26
- Immunotherapy and Immune Responses 21
- Co-authors
- David M. GoldenbergRobert M. SharkeySidney BennettD M GoldenbergFrank H. DeLandJohn R. van NagellNorman EstesPaolo De Simone
- Journals
- International Journal of Cancer (7 papers)Cancer (5 papers)JNCI Journal of the National Cancer Institute (4 papers)Cancer Immunology Immunotherapy (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
F. James Primus
77 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Radiology, Nuclear Medicine and Imaging 2.1k
- Immunology 936
- Oncology 1.1k
- Biotechnology 208
- Molecular Biology 1.2k
Countries citing papers authored by F. James Primus
This map shows the geographic impact of F. James Primus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. James Primus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. James Primus more than expected).
Fields of papers citing papers by F. James Primus
This network shows the impact of papers produced by F. James Primus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. James Primus. The network helps show where F. James Primus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. James Primus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 45 | |
| 2 | 2005 | 24 | |
| 3 | 2004 | 26 | |
| 4 | 2001 | 79 | |
| 5 | 2001 | 46 | |
| 6 | 2000 | 3 | |
| 7 | 1994 | 23 | |
| 8 | 1994 | 3 | |
| 9 | 1993 | 7 | |
| 10 | Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes. | 1993 | 9 |
| 11 | 1991 | 10 | |
| 12 | 1990 | 9 | |
| 13 | 1990 | 7 | |
| 14 | 1989 | 26 | |
| 15 | 1989 | 47 | |
| 16 | 1988 | 35 | |
| 17 | 1981 | 23 | |
| 18 | Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. | 1977 | 49 |
| 19 | Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors. | 1976 | 13 |
| 20 | 1974 | 10 |
About F. James Primus
F. James Primus is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Immunology and Allergy and Biotechnology, having authored 77 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (39 papers), Radiopharmaceutical Chemistry and Applications (35 papers), Immunotherapy and Immune Responses (21 papers), Glycosylation and Glycoproteins Research (12 papers), CAR-T cell therapy research (8 papers), Medical Imaging and Pathology Studies (7 papers), Virus-based gene therapy research (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.1k citations), Immunology (936 citations), Oncology (1.1k citations), Biotechnology (208 citations) and Molecular Biology (1.2k citations). F. James Primus has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include David M. Goldenberg, Robert M. Sharkey, Sidney Bennett, D M Goldenberg, Frank H. DeLand, John R. van Nagell, Norman Estes, Paolo De Simone, F. H. DeLand and Jean F. Simpson. Their work appears in journals such as International Journal of Cancer, Cancer, JNCI Journal of the National Cancer Institute, Cancer Immunology Immunotherapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.